These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16920558)

  • 21. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
    Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
    Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
    Ayuk F; Diyachenko G; Zabelina T; Wolschke C; Fehse B; Bacher U; Erttmann R; Kröger N; Zander AR
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):913-9. PubMed ID: 18640575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?
    Dubberke ER; Hollands JM; Georgantopoulos P; Augustin K; DiPersio JF; Mundy LM; Khoury HJ
    Bone Marrow Transplant; 2006 Dec; 38(12):813-9. PubMed ID: 17057724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
    J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience.
    Jaing TH; Tsay PK; Yang CP; Hung IJ; Wen YC; Tseng CK
    Transplant Proc; 2008 Dec; 40(10):3643-5. PubMed ID: 19100457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: a meta-regression analysis.
    van Gestel JP; Bollen CW; van der Tweel I; Boelens JJ; van Vught AJ
    Crit Care Med; 2008 Oct; 36(10):2898-904. PubMed ID: 18766109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases.
    Miyakoshi S; Kusumi E; Matsumura T; Hori A; Murashige N; Hamaki T; Yuji K; Uchida N; Masuoka K; Wake A; Kanda Y; Kami M; Tanaka Y; Taniguchi S
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):771-7. PubMed ID: 17580255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic stem cell transplantation in patients with active fungal infection: not a contraindication for transplantation.
    Aki ZS; Sucak GT; Yeğin ZA; Güzel O; Erbaş G; Senol E
    Transplant Proc; 2008 Jun; 40(5):1579-85. PubMed ID: 18589155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of centre and period effects in allogeneic haematopoietic stem cell transplantation in France.
    Mesnil F; Jouet JP; Tuppin P; Vernant JP; Golmard JL
    Bone Marrow Transplant; 2004 Oct; 34(7):645-51. PubMed ID: 15300230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation.
    Wong AS; Chan KH; Cheng VC; Yuen KY; Kwong YL; Leung AY
    Clin Infect Dis; 2007 Mar; 44(6):830-7. PubMed ID: 17304456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.
    Poutsiaka DD; Price LL; Ucuzian A; Chan GW; Miller KB; Snydman DR
    Bone Marrow Transplant; 2007 Jul; 40(1):63-70. PubMed ID: 17468772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse.
    Yakoub-Agha I; Saule P; Magro L; Cracco P; Duhamel A; Coiteux V; Bruno B; Dufossé F; Jouet JP; Dessaint JP; Labalette M
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence.
    Rao K; Darrington DL; Schumacher JJ; Devetten M; Vose JM; Loberiza FR
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1508-14. PubMed ID: 18022581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological distress as a negative survival factor for patients with hematologic malignancies who underwent allogeneic hematopoietic stem cell transplantation.
    Park JE; Kim KI; Yoon SS; Hahm BJ; Lee SM; Yoon JH; Shin WG; Lee HS; Oh JM
    Pharmacotherapy; 2010 Dec; 30(12):1239-46. PubMed ID: 21114391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD.
    Holler E; Kolb HJ; Greinix H; Perrotin D; Campilho F; Aversa F; Gil L; Cornelissen J; Varanese L; Schacht A; Friese A; Rustige J
    Bone Marrow Transplant; 2009 Mar; 43(6):491-7. PubMed ID: 19079317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.
    Nakayama K; Tannir NM; Liu P; Wathen JK; Cheng YC; Champlin RE; Ueno NT
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):975-85. PubMed ID: 17640602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.